Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot studyDOMENECH, E; HINOJOSA, J; ESTEVE-COMAS, M et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 11-12, pp 1347-1352, issn 0269-2813, 6 p.Article

Aminosalicylates in inflammatory bowel diseaseHANAUER, S. B.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 4, pp 60-65, issn 0953-0673, 6 p.Article

Helminths as therapeutic agents for inflammatory bowel diseaseHUNTER, M. M; MCKAY, D. M.Alimentary pharmacology & therapeutics. 2004, Vol 19, Num 2, pp 167-177, issn 0269-2813, 11 p.Article

Advances in inflammatory bowel disease : Diagnosis and therapyTORRES, M. I; RIOS, A.Recent research developments in life science (Vol. 2 (2004)). Recent research developments in life science. 2004, pp 195-215, isbn 81-7736-216-X, 21 p.Book Chapter

Le pentasa : traitement d'attaque et d'entretien des maladies inflammatoires intestinales = The PENTASA: Attack and maintenance treatment in inflammatory bowel diseaseCHEVREL, B.Médecine et chirurgie digestives (Paris). 1989, Vol 18, Num 7, pp 431-436, issn 0047-6412, 6 p.Article

Patients' fears and unmet needs in inflammatory bowel diseaseIRVINE, E. J.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 4, pp 54-59, issn 0953-0673, 6 p.Article

The genetics of chronic inflammatory diseasesHEAP, Graham A; VAN HEEL, David A.Human molecular genetics (Print). 2009, Vol 18, issn 0964-6906, R101-R106, NS1Article

Nutritional concerns in pediatric inflammatory bowel disease patients : Nutrition and inflammatory bowel diseaseKAPPELMAN, Michael D; BOUSVAROS, Athos.Molecular nutrition & food research (Print). 2008, Vol 52, Num 8, pp 867-874, issn 1613-4125, 8 p.Article

A prospective assessment of cytomegalovirus infection in active inflammatory bowel diseaseDE SAUSSURE, P; LAVERGNE-SLOVE, A; MAZERON, M.-C et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 11-12, pp 1323-1327, issn 0269-2813, 5 p.Article

Impact of inflammatory disease on the nerve microenvironmentPOWELL, Henry C; MYERS, Robert R.Journal of the neurological sciences. 2004, Vol 220, Num 1-2, pp 131-132, issn 0022-510X, 2 p.Conference Paper

Gut flora and inflammatory bowel diseaseMARTEAU, P; LEPAGE, P; MANGIN, I et al.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 4, pp 18-23, issn 0953-0673, 6 p.Article

Antibiotics and probiotics in inflammatory bowel diseaseKRUIS, W.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 4, pp 75-78, issn 0953-0673, 4 p.Article

Spleen size in patients with inflammatory bowel disease: does it have any clinical significance?PEREIRA, J. L. R; HUGHES, L. E; YOUNG, H. L et al.Diseases of the colon & rectum. 1987, Vol 30, Num 6, pp 403-409, issn 0012-3706Article

Circulating galectin-3 in infections and non-infectious inflammatory diseasesTEN OEVER, J; GIAMARELLOS-BOURBOULIS, E. J; NETEA, M. G et al.European journal of clinical microbiology & infectious diseases (Print). 2013, Vol 32, Num 12, pp 1605-1610, issn 0934-9723, 6 p.Article

Muscle weakness, palpitations and a small chin: the Andersen-Tawil syndromeRAJAKULENDRAN, S; TAN, S. V; HANNA, M. G et al.Practical neurology (Print). 2010, Vol 10, Num 4, pp 227-231, issn 1474-7758, 5 p.Article

Imaging of Primary and Secondary Inflammatory Diseases Involving Large and Medium-Sized Vessels and Their Potential Mimics: A Multitechnique ApproachSPIRA, Daniel; KÖTTER, Ina; ERNEMANN, Ulrike et al.American journal of roentgenology (1976). 2010, Vol 194, Num 3, pp 848-856, issn 0361-803X, 9 p.Article

The role of nitric oxideKOLB-BACHOFEN, V; KUHN, A; SUSCHEK, C. V et al.Rheumatology (Oxford. Print). 2006, Vol 45, issn 1462-0324, iii17-iii19, SUP3Article

Role of biological agents in immune-mediated inflammatory diseasesEFTHIMIOU, Petros; MARKENSON, Joseph A.Southern medical journal (Birmingham). 2005, Vol 98, Num 2, pp 192-204, issn 0038-4348, 13 p.Article

The role of STATs in inflammation and inflammatory diseases : Transcription factors as targets of novel therapeutic approaches of autoimmune diseasesPFITZNER, E; KLIEM, S; BAUS, D et al.Current pharmaceutical design. 2004, Vol 10, Num 23, pp 2839-2850, issn 1381-6128, 12 p.Article

The role of nutrition in the treatment of inflammatory bowel diseaseGASSULL, M. A.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 4, pp 79-83, issn 0953-0673, 5 p.Article

The genetics of Crohn disease: complex segregation analysis of a family study with 265 patients with Crohn disease and 5387 relativesKÜSTER, W; PASCOE, L; PURRMANN, J et al.American journal of medical genetics. 1989, Vol 32, Num 1, pp 105-108, issn 0148-7299, 4 p.Article

Zur Ätiologie chronisch-entzündlicher Darmerkrankungen = Sur l'étiologie des maladies intestinales inflammatoires chroniques = On the aetiology of chronic inflammatory bowel diseasesPURRMANN, J; MILLER, B; STROHMEYER, G et al.Zeitschrift für Gastroenterologie. 1986, Vol 24, Num 7, pp 357-363, issn 0044-2771Article

Glucocorticoid resistance in inflammatory diseasesBARNES, Peter J; ADCOCK, Ian M.Lancet (British edition). 2009, Vol 373, Num 9678, pp 1905-1917, issn 0140-6736, 13 p.Article

Azathioprine dose escalation in inflammatory bowel diseaseRAYNER, C. K; HART, A. L; HAYWARD, C. M. M et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 1, pp 65-71, issn 0269-2813, 7 p.Article

Inflammatory bowel disease and hospital treatment in Italy: the RING multi-centre studySONCINI, M; TRIOSSI, O; LEO, P et al.Alimentary pharmacology & therapeutics. 2004, Vol 19, Num 1, pp 63-68, issn 0269-2813, 6 p.Article